Starton Therapeutics
Kiriakos Charlie Perperidis serves as the President of Kiriakos Capital LTD and has been a Co-Founder of Starton Therapeutics since May 2016. With a background in leadership and entrepreneurship, Kiriakos is instrumental in driving innovative solutions within the healthcare sector through Starton Therapeutics.
This person is not in any teams
This person is not in any offices
Starton Therapeutics
Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary transdermal technology, so people with cancer can receive continuous treatment to live better, longer.